Your browser doesn't support javascript.
loading
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.
Chabala, Chishala; Turkova, Anna; Hesseling, Anneke C; Zimba, Kevin M; van der Zalm, Marieke; Kapasa, Monica; Palmer, Megan; Chirehwa, Maxwell; Wiesner, Lubbe; Wobudeya, Eric; Kinikar, Aarti; Mave, Vidya; Hissar, Syed; Choo, Louise; LeBeau, Kristen; Mulenga, Veronica; Aarnoutse, Robb; Gibb, Diana; McIlleron, Helen.
Afiliação
  • Chabala C; University of Zambia, School of Medicine, Department of Paediatrics, Lusaka, Zambia.
  • Turkova A; University of Cape Town, Faculty of Health Sciences, Department of Medicine, Division of Clinical Pharmacology, Cape Town, South Africa.
  • Hesseling AC; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Zimba KM; Medical Research Council-Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, United Kingdom.
  • van der Zalm M; University of Stellenbosch, Desmond Tutu Tuberculosis Centre, Cape Town, South Africa.
  • Kapasa M; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Palmer M; University of Stellenbosch, Desmond Tutu Tuberculosis Centre, Cape Town, South Africa.
  • Chirehwa M; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Wiesner L; University of Stellenbosch, Desmond Tutu Tuberculosis Centre, Cape Town, South Africa.
  • Wobudeya E; University of Cape Town, Faculty of Health Sciences, Department of Medicine, Division of Clinical Pharmacology, Cape Town, South Africa.
  • Kinikar A; University of Cape Town, Faculty of Health Sciences, Department of Medicine, Division of Clinical Pharmacology, Cape Town, South Africa.
  • Mave V; Makerere University-Johns Hopkins University Care Ltd, Kampala, Uganda.
  • Hissar S; Byramjee Jeejeebhoy Government Medical College, Pune, India.
  • Choo L; Byramjee Jeejeebhoy Government Medical College, Pune, India.
  • LeBeau K; India Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, India.
  • Mulenga V; Medical Research Council-Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, United Kingdom.
  • Aarnoutse R; Medical Research Council-Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, United Kingdom.
  • Gibb D; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • McIlleron H; Radboud University Medical Center, Nijmegen, The Netherlands.
Clin Infect Dis ; 74(10): 1767-1775, 2022 05 30.
Article em En | MEDLINE | ID: mdl-34420049
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Limite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Limite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article